In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.

The new triazole derivative SCH 56592 has been tested in a National Committee for Clinical Laboratory Standards-adapted in vitro susceptibility test, and its activity against 12 isolates of Blastomyces dermatitidis yeast-like forms has been compared with those of amphotericin B, itraconazole, and fl...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Sugar, A M, Liu, X P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163319/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723494/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1314
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!